Ms. Curfs studied Environmental Health Sciences and holds a PhD in Toxicology and Cardiovascular Diseases. She continued as a postdoctoral research fellow in a public private partnership between the former pharmaceutical company Organon, Maastricht University and the Dutch government, setting up high-throughput screening methods. In 2009, she transferred to Royal DSM and started working as a project manager in the public-private BioMedical Materials Program, managing a project portfolio of M€50 in the fields of cardiovascular, nephrology and drug delivery. In 2014, she switched to DSM’s Innovation Center as the program director of DSM’s global competence program Health. Simultaneously she was involved in setting up the public-private Institute for Science and Technology (InSciTe).
As of 2016, she dedicates her time on developing a matrix concept to accelerate (bio)medical innovations towards market and patient. This matrix concept is the foundation of Medace: a full service company that trains and guides its customers (being academics or entrepreneurs), in an ISO-certified work-learning environment, how to set up and develop the technical dossier needed for clinical validation whilst producing their clinical grade product.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.